These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.
    Author: Işık M, Kaya Z, Belen FB, Aktaş AT, Tezer H, Gürsel T.
    Journal: J Pediatr Hematol Oncol; 2014 Jan; 36(1):e46-8. PubMed ID: 23007418.
    Abstract:
    Dipyrone or metamizole Na (Novalgin) is commonly used as an antipyretic, analgesic, and spasmolytic agent in some parts of the world; however, it is banned in developed countries because of severe side effects. Here we present a case of a 4-year-old boy who developed life-threatening agranulocytosis, anemia, and marked plasmacytosis in his bone marrow after dipyrone use for fever, which resolved with steroid therapy.
    [Abstract] [Full Text] [Related] [New Search]